Scientific conference spotlights PYC's work on blindness disease treatment
PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
BNZ | Ann: Fitch Outlook Revision | 22/02/19 | 0 | 101 | |||
|
|||||||
BNZ | Ann: NAB 2019 First Quarter Pillar 3 Report | 08/02/19 | 0 | 106 | |||
|
|||||||
BNZ | Ann: NAB 2019 First Quarter Trading Update | 08/02/19 | 0 | 111 | |||
|
|||||||
BNZ | Ann: Philip Chronican to retire from the BNZ Board | 08/02/19 | 0 | 106 | |||
|
|||||||
BNZ | Ann: BNZ announces appointments to the Executive Team | 01/02/19 | 0 | 112 | |||
|
|||||||
BNZ | Ann: BNZ announces change to Executive Team | 15/01/19 | 0 | 129 | |||
|
|||||||
BNZ | Ann: Proposed share issue by BNZ | 05/12/18 | 0 | 166 | |||
|
|||||||
BNZ | Ann: BNZ Disclosure Statement - 30 September 2018 | 05/12/18 | 0 | 170 | |||
|
See All Discussions